antalarmin has been researched along with yohimbine in 4 studies
Studies (antalarmin) | Trials (antalarmin) | Recent Studies (post-2010) (antalarmin) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
---|---|---|---|---|---|
181 | 0 | 76 | 5,893 | 253 | 532 |
Protein | Taxonomy | antalarmin (IC50) | yohimbine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Epstein, DH; Ghitza, UE; Gray, SM; Rice, KC; Shaham, Y | 1 |
Funk, D; Harding, S; Juzytsch, W; Lê, AD; Marinelli, PW; Rice, KC; Shaham, Y | 1 |
Coen, K; Funk, D; Lê, AD | 1 |
Bhat, S; Georgiou, P; Gould, TD; McCarthy, MM; Merchenthaler, IJ; Tracy, JK; Zanos, P | 1 |
4 other study(ies) available for antalarmin and yohimbine
Article | Year |
---|---|
The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Food Preferences; Interpersonal Relations; Male; Pyrimidines; Pyrroles; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Yohimbine | 2006 |
The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.
Topics: Adrenergic alpha-Antagonists; Alcoholism; Animals; Behavior, Addictive; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Male; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration; Yohimbine | 2007 |
The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Cues; Drug-Seeking Behavior; Ethanol; Male; Naltrexone; Narcotic Antagonists; Pyrimidines; Pyrroles; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, kappa; Self Administration; Stress, Physiological; Yohimbine | 2014 |
Dopamine and Stress System Modulation of Sex Differences in Decision Making.
Topics: Adrenergic alpha-2 Receptor Antagonists; Amygdala; Animals; Behavior, Animal; Decision Making; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Female; Male; Pyrimidines; Pyrroles; Quinpirole; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Dopamine D2; Salicylamides; Sex Characteristics; Yohimbine | 2018 |